Safety and immunogenicity following a homologous booster dose of CoronaVac in children and adolescents

oleh: Lei Wang, Zhiwei Wu, Zhifang Ying, Minjie Li, Yuansheng Hu, Qun Shu, Jing Li, Huixian Wang, Hengming Zhang, Wenbin Jiao, Lin Wang, Yuliang Zhao, Qiang Gao

Format: Article
Diterbitkan: Nature Portfolio 2022-11-01

Deskripsi

Few countries have approved SARS-CoV-2 booster doses in children and adolescents due to insufficient evidence about the safety and interval vaccination. Here, the authors assess the safety and immunogenicity of a homologous booster dose of CoronaVac in a cohort of 3–17 year olds.